Health Care & Life Sciences » Pharmaceuticals | Ocular Therapeutix Inc.

Ocular Therapeutix Inc. | Key People and Executives

Amarpreet S. Sawhney
Executive Chairman
Antony Mattessich
President, Chief Executive Officer & Director
Jaswinder S. Chadha
Director
William James O'Shea
Independent Director
Jeffrey S. Heier
Independent Director
Bruce A. Peacock
Independent Director
Richard L. Lindstrom
Independent Director
Charles M. Warden
Lead Independent Director
Amarpreet S. Sawhney
Executive Chairman
Antony Mattessich
President, Chief Executive Officer & Director
Donald Notman
Chief Financial & Accounting Officer
Michael H. Goldstein
Chief Medical Officer
Peter Jarrett
Chief Scientific Officer
Pauline Jen Ryan
Head-Business & Corporate Development
Scott Corning
Senior Vice President-Commercial
Kevin Hanley
Senior Vice President-Technical Operations
Naymisha Patel
Vice President-Quality
Jaswinder S. Chadha
Director
Nicole Carta
Director-Human Resources
Jonathan M. Sparks
General Counsel
Daniel M. Bollag
Senior Vice President-Regulatory Affairs & Quality
William James O'Shea
Independent Director
Jeffrey S. Heier
Independent Director
Bruce A. Peacock
Independent Director
Richard L. Lindstrom
Independent Director
Charles M. Warden
Lead Independent Director

About Ocular Therapeutix

View Profile
Address
15 Crosby Drive
Bedford Massachusetts 01730
United States
Employees -
Website http://www.ocutx.com
Updated 07/08/2019
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S.